Azacitidine in a patient with myelodysplastic syndrome:...

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

M.T. Voso, L. Fianchi, M. Criscuolo, M. Greco, F. D’Alo, S. Hohaus, L. Pagano, G. Leone
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.leukres.2011.08.010
File:
PDF, 205 KB
english, 2012
Conversion to is in progress
Conversion to is failed